Most patients find that semaglutide naturally reduces calorie intake without strict counting, but logging meals for one week can reveal eating patterns and confirm you're not overeating despite reduced appetite
LSD, DMT, and ketamine lozenges can all be taken this way
The SELECT trial showed that semaglutide reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in adults with obesity and established cardiovascular disease, without requiring a diabetes diagnosis. The FLOW trial showed kidney benefits with semaglutide use in patients with type 2 diabetes and chronic kidney disease. Improvements in hard clinical outcomes like cardiac events, kidney disease, and death are commonly observed with GLP-1 use, and are due to both the direct effects of treating the obesity, and indirect effects of the medications themselves
Novo Nordisk deploys a recombinant yeast-based fermentation method to produce the backbone of liraglutide and semaglutide, followed by solid-phase synthesis to make certain additions and modifications to the backbone
DECISION GUIDE Which Should You Take
